跳至主要内容
临床试验/CTRI/2020/04/024947
CTRI/2020/04/024947尚未招募3 期

Drug Proving & checking its effectiveness in treatment of COVID 19

Dr Priti katre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 COVID affected individual (serologically positive) symptomatic, mild hospitalized
  • 2 asymptomatic (serologically positive)

排除标准

  • 1.Malabsorption or inadequate oral intake
  • 2.unexplained, chronic diarrhea, defined as more than 3 loose stool per day persisting for 2 weeks or more within the month prior to study entry.
  • 3. Active malignancy or anticipated need for chemotherapy during the study

研究者

发起方
Dr Priti katre

相似试验